Form 8-K - Current report:
SEC Accession No. 0001437749-25-024847
Filing Date
2025-08-05
Accepted
2025-08-05 16:05:36
Documents
13
Period of Report
2025-08-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20250805_8k.htm   iXBRL 8-K 27803
  Complete submission text file 0001437749-25-024847.txt   158015

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crvo-20250805.xsd EX-101.SCH 3578
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20250805_def.xml EX-101.DEF 11423
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20250805_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20250805_pre.xml EX-101.PRE 11583
15 EXTRACTED XBRL INSTANCE DOCUMENT crvo20250805_8k_htm.xml XML 2847
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 251184898
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)